. . . . . . . . . "The purpose of this review is to summarize the current evidence of the off-label use of intravenous (IV) olanzapine and discuss its risks versus benefits for the management of agitation." . . . . . . "Adults" . . "2021-08-24T19:04:46.392178"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "SlaR0TqX8SrVotaTJDVKXuIMhGoIN6385wzSIZLVgNOvjd/t1nr5G47c6E702scuBtd5uoGX//W0Y90AaV/PdF5fMr2x7u/zNfH9mh77zWHiVxHo+EqBTy/uWP7bSYpxpVtCFZLSfnmWhHyc6cisH4BX4Zy1+Nnxufer+Jdg6kA=" . . "2021-08-24T19:04:46.392178"^^ . . .